Enterome Bioscience raises $16.5 mln
Enterome Bioscience SA said April 20 it raised 14.5 million euroes ($16.5 million) in Series C financing led by existing investors, such as Seventure (including from its new Health for Life Capital fund) and Lundbeckfond Ventures, and included new investors. Nestlé Health Science also participated. Paris-based Enterome develops pharmaceuticals and diagnostics based on the gut microbiome.
20 April 2016•4 mins read
